ArticleJournal of surgical oncology2017

Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer.

Muhammad Shaalan Beg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.